coopervision.com Open in urlscan Pro
184.72.249.120  Public Scan

Form analysis
1 forms found in the DOM

POST /our-company/news-center/press-release/coopervision-introduces-myday-daily-disposable-multifocal?_hsmi=179372714&_hsenc=p2ANqtz-_Rqrtdi9bvwBPsyfT4VLrJSiBVJSSSNAidrfnJRcCTyMmybo6Cgfosmp4xL9t6MaAj9nzRA9ZqE1iTSPkwOEljAYamjg

<form action="/our-company/news-center/press-release/coopervision-introduces-myday-daily-disposable-multifocal?_hsmi=179372714&amp;_hsenc=p2ANqtz-_Rqrtdi9bvwBPsyfT4VLrJSiBVJSSSNAidrfnJRcCTyMmybo6Cgfosmp4xL9t6MaAj9nzRA9ZqE1iTSPkwOEljAYamjg"
  method="post" id="search-api-page-search-form-site-search" accept-charset="UTF-8">
  <div>
    <div class="container-inline">
      <div class="form-item form-type-textfield form-item-keys-66">
        <label class="element-invisible" for="edit-keys-66">Enter your keywords </label>
        <input placeholder="Search" type="text" id="edit-keys-66" name="keys_66" value="" size="15" maxlength="128" class="form-text">
      </div>
      <div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit-66" name="op" value="Search" class="form-submit"></div><input type="hidden" name="id" value="66">
      <input type="hidden" name="form_build_id" value="form-cTuD8mwdaWbm_SYLhQsRMpBi8YIjKQFGpsT5LBhzmRI">
      <input type="hidden" name="form_id" value="search_api_page_search_form_site_search">
    </div>
  </div>
</form>

Text Content

Skip to main content
 * Practitioner Site
 * Patient Information Booklets
 * Find an Eye Doctor
 * Contact Us
 * United States


Menu
 * Our Products
   * MyDay family
     * MyDay daily disposable
     * MyDay daily disposable toric
     * MyDay daily disposable multifocal
   * clariti 1 day family
     * clariti 1 day
     * clariti 1 day toric
     * clariti 1 day multifocal
   * Biofinity family
     * Biofinity
     * Biofinity Energys
     * Biofinity toric
     * Biofinity multifocal
     * Biofinity® toric multifocal
   * Avaira Vitality family
     * Avaira Vitality
     * Avaira Vitality toric
   * MiSight 1 day
   * Additional products
   * Find A Lens Quiz
   * Contact Lens Technology
     * Aberration Neutralizing System™
     * ActivControl® Technology
     * Aquaform Technology
     * Balanced Progressive Technology
     * Binocular Progressive System™
     * Digital Zone Optics® lens design
     * Optimized Toric Lens Geometry
     * PC Technology
     * WetLoc® Technology
   * Patient Instruction & Information Booklets
   * Aftercare Solutions
 * Contact Lenses & Vision
   * Blog
   * Digital device usage report
   * Digital eye fatigue
   * How to use hydrogen peroxide solutions
   * How to use multipurpose solutions
   * New wearer
   * Experienced wearer
 * About Us
   * Careers
     * Benefits
     * Career development
     * Our inclusive culture
     * Wellness
     * Warning of fraudulent online employment scams
   * Corporate social responsibility
     * Opening Eyes
   * Our work and values
   * Innovative technology
   * Science and Technology Awards
   * Supplier Code of Conduct
   * Educational Grants & Sponsorships
   * CooperVision & Sustainability
     * Saving Water
     * Conserving Energy
     * Reducing, Reusing, Recycling
     * Empowering People
     * Sustainability News & Accolades
     * Sustainability Report Card
   * Global news
     * CooperVision Announces the Opening of new site in Costa Rica
     * CooperVision COVID-19 Company Statement
     * CooperVision Statement on COVID-19 and Contact Lens Wear
     * CooperVision World Sight Day 2021
   * Leadership
   * Awards
   * Contact Us
 * Find an Eye Doctor
 * Myopia Management

Search
Enter your keywords



Hello! Let’s help you get started…

Click to get started Tap to get started





YOU ARE HERE

Home > Our Company > News > Press Release > CooperVision Introduces MyDay® Daily
Disposable Multifocal Contact Lenses in U.S. at 2021 American Academy of
Optometry Meeting


COOPERVISION INTRODUCES MYDAY® DAILY DISPOSABLE MULTIFOCAL CONTACT LENSES IN
U.S. AT 2021 AMERICAN ACADEMY OF OPTOMETRY MEETING

November 03, 2021

Innovative Binocular Progressive System™ Features a 3 ADD System to Provide
Optimal Vision at All Distances, Spanning Younger Presbyopes to Patients with
More Advanced Presbyopia

BOSTON, November 3, 2021—At the 2021 American Academy of Optometry Meeting,
CooperVision today introduced MyDay® daily disposable multifocal contact lenses,
expanding its popular premium silicone hydrogel 1 day family in the United
States.

The new lenses are the first to feature the CooperVision® Binocular Progressive
System™, an innovative 3 ADD approach that caters to all levels of presbyopia
with a simple fitting process,1+ optimal visual acuity at all distances and
comfortable wear for exceptional performance.2 Eye care professionals (ECPs) can
successfully fit 98% of patients with two pairs of MyDay® multifocal lenses or
fewer when following the fitting guide.1

“As people age into presbyopia, they often turn to reading glasses over their
contact lenses or drop out entirely,3” said Michele Andrews, OD, Vice President
of Professional and Government Affairs, Americas, CooperVision. “These patients
need a contact lens that checks all the boxes: excellent vision, comfort, and
ocular health.4 MyDay® multifocal will help ECPs further build their practices
and energize the category.”

“MyDay® multifocal is a true game-changer in the presbyopic realm. It caters to
a large demographic of our patients that need and can benefit from contact
lenses,” said Harmin Chima, OD, of Family First Vision Care-Legacy Village in
Cleveland. Dr. Chima is among a select group of U.S. ECPs who began evaluating
the new lenses this summer.

At launch, MyDay® multifocal will be available in the broadest range of any
daily disposable multifocal contact lens on the market,5 with an 8.4 mm base
curve, 14.2 mm diameter and an extensive power range from +8.00D to -10.00D (in
0.25D steps) and -10.50D to -12.00D (in 0.50D steps). The three ADD powers
include low (+0.75D to +1.25D spectacle Rx ADD), medium (+1.50D to +1.75D
spectacle Rx ADD) and high (+2.00D to +2.50D spectacle Rx ADD). Oxygen
transmissibility (Dk/t) at -3.00D is 100 x 10-9 and the lenses offer 85% UVA and
96% UVB blocking.*

Fitting, Vision and Comfort Innovations

The CooperVision® Binocular Progressive System™ debuts with MyDay® multifocal.
The 3 ADD method uses different lens designs to optimize vision for all levels
of presbyopia.6 These allow the eyes to work in tandem, which gives a simple
initial fit and an easy progression as the near requirement increases. Wearers
embrace the lens from the start, with 100% overall fit acceptance on
dispensing.1 That performance helps wearers get back on the go and spend more
time on the things that matter most to them—and may give ECPs more time to fit
more patients.

“ECPs recognize the opportunities that MyDay® multifocal present for their
patients and their practices. In a recent assessment, 100% of ECPs agreed that
MyDay® multifocal contact lenses are a better option for their patients than
fitting single vision MyDay® lenses with reading glasses.2 In addition, 98% of
ECPs agreed that MyDay® multifocal contact lenses are an excellent option for
new patients with presbyopia who are interested in wearing contact lenses,2”
said CooperVision’s Dr. Andrews.

Raj Patel, OD, FAAO, of Vancouver Vision Clinic in Washington State has also
been among the first U.S. ECPs to assess the new lens. “CooperVision has done a
fantastic job designing MyDay® multifocals in a way that I can fit the lenses in
a really short amount of time.2 The patient outcomes are high.7 They're
comfortable. Patients are seeing well.2 You have to try it; it's a great, great
lens for presbyopes,” he remarked.

Fitting the new lens is made easier with OptiExpert™—a suite of tools to aid in
fitting decisions, reduce chair time8 and increase patient success. This
includes a new capability of refining first fit for vision optimization.
OptiExpert™ is available to download on the Apple App Store and Google Play. The
desktop version can be used at
https://coopervision.com/practitioner/tools-and-calculators/optiexpert/optiexpert-web.

Eye care professionals attending Academy 2021 in Boston can join the MyDay®
multifocal launch event on Thursday, November 4 at 5 p.m. ET. The education
reception takes place at the NW Lobby Area on level 1, directly below the level
2 charging lounge. It will include an overview of the lens features plus
observations and clinical insights from the earliest prescribers. In addition,
attendees can visit CooperVision’s booth #613 to take part in the MyDay®
multifocal marketing campaign, “Game On, Presbyopia."

For additional information, please visit
https://coopervision.com/practitioner/our-products/myday-family/myday-multifocal.

+Leveraging the fitting guide.

*Warning: UV-absorbing contact lenses are not substitutes for protective
UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they
do not completely cover the eye and surrounding area. Patients should continue
to use UV-absorbing eyewear as directed.

References:

1. CVI data on file 2020. Prospective, double-masked, bilateral, one-week
dispensing study UK with MyDay® daily disposable multifocal; n=104 habitual
multifocal contact lens wearers; CVI data on file 2021. Prospective,
subject-masked, randomized, bilateral, two-week dispensing study at 5 US sites
with MyDay® daily disposable multifocal; n=58 habitual multifocal contact lens
wearers.

2. CVI data on file 2021. Observational in-practice assessment with MyDay®
multifocal in US with 40 ECPs and 372 wearers.

3. Akerman D. 40 is the New 20/20 — Presbyopia Equals Opportunity. CL Spectrum,
March 2010.

4. CVI data on file 2020. Kubic Online Survey with spherical soft contact lens
wearers with presbyopia/symptoms.  N= 1005 (555 1 Day, 450 FRP wearers). US, UK,
JP; weighted equally.

5. CooperVision data on file 2021. Based on prescription option combinations
(sph and add) available across all daily disposable multifocal soft lenses from
CVI, JJV, B+L and Alcon in USA May 2021.

6. CVI data on file 2020. Prospective, double-masked, bilateral, 1-week
dispensing study with MyDay daily disposable multifocal; n=104 habitual MFCL
wearers.

7. Initial dispensing visit. CVI data on file 2021. Observational in-practice
assessment with MyDay® multifocal in US with 48 ECPs and 372 wearers.

8. Based on retrospective analysis of 26 patients (52 eyes) with subjective
refractions ranging between +5.00D to -6.00D and ≤ -1.00 D cylinder.

# # #

About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s
leading manufacturers of contact lenses. The company produces a full array of
daily disposable, two-week and monthly soft contact lenses that feature advanced
materials and optics, and premium rigid gas permeable lenses for orthokeratology
and scleral designs. CooperVision has a strong heritage of addressing the
toughest vision challenges such as astigmatism, presbyopia, childhood myopia,
and highly irregular corneas; and offers the most complete portfolio of
spherical, toric and multifocal products available. Through a combination of
innovative products and focused practitioner support, the company brings a
refreshing perspective to the marketplace, creating real advantages for
customers and wearers. For more information, visit www.coopervision.com.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on
the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision
and CooperSurgical. CooperVision brings a refreshing perspective on vision care
with a commitment to developing a wide range of high-quality products for
contact lens wearers and providing focused practitioner support. CooperSurgical
is committed to advancing the health of women, babies and families with its
diversified portfolio of products and services focusing on medical devices and
fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce
of more than 12,000 with products sold in over 100 countries. For more
information, please visit www.coopercos.com. 

Media Contact
Heather Kowalczyk, APR, McDougall Communications
heather@mcdougallpr.com or +1-585-434-2148

More News Articles


PUBLIC RELATIONS

PublicRelations@coopervision.com

(585) 264-3263
 
Also of Interest:
 * How to Put Contacts in Your Eyes
 * Our Products
 * Find an eye doctor


AWARDS

 * 
 * 
 * 
 * 
 * 
 * 

facebook twitter instagram
 * Our products
    * Find a lens quiz
    * Patient information booklets
    * Contact lens technology

 * Find an eye doctor
 * Contact Lenses & Vision
    * New wearer
    * Experienced wearer
    * Blog

 * About us
    * Careers
    * Global news
    * Contact us

 * Legal
    * Privacy policy
    * California Privacy Policy
    * Terms of service
    * CA Transparency & UK Modern Slavery Act


© 2021 CooperVision | Part of CooperCompanies


LET’S GET STARTED.

I’m interested in wearing contact lenses I’m already wearing contact lenses
MyDay family
 * MyDay daily disposable
 * MyDay daily disposable toric
 * MyDay multifocal


clariti 1 day family
 * clariti 1 day
 * clariti 1 day toric
 * clariti 1 day multifocal


MiSight 1 day
 * MiSight 1 day

Biofinity family
 * Biofinity & Biofinity XR
 * Biofinity Energys
 * Biofinity toric & Biofinity XR toric
 * Biofinity multifocal
 * Biofinity toric multifocal


Avaira Vitality family
 * Avaira Vitality
 * Avaira Vitality toric

Additional products

Find a lens quiz

Contact lens technology

Can't find your brand?

Patient instruction

AfterCare Solutions

 * Blog
 * Digital device usage report
 * Digital eye fatigue
 * How to use hydrogen peroxide solutions
 * How to use multipurpose solutions
 * New wearer
 * Experienced wearer

 * Careers
 * Corporate social responsibility
 * Our work and values
 * Innovative technology
 * Science and Technology Awards
 * Supplier Code of Conduct
 * Educational Grants & Sponsorships
 * CooperVision & Sustainability
 * Global news
 * Leadership
 * Awards
 * Contact Us